35th International Symposium on ALS/MND

Montreal, Canada

6-8th December 2024

Axoltis Pharma is thrilled to announce our participation in the upcoming 35th International Symposium on ALS/MND in Montreal, Canada

Dr Annette Janus, MD, Chief Medical Officer, is glad to attend and to present “NX210c for recovering Blood Brain Barrier integrity in ALS patients in silico modelling complements statistical analysis of fluid biomarkers for dose selection and design of a phase II study (SEALS)” on Saturday December 7th 5:30pm EST – Poster session
 
This International Symposium is the biggest annual conference dedicated to ALS and MND research. Each year it brings together researchers from around the world to share new understanding of amyotrophic lateral sclerosis and motor neurone disease.